NasdaqGS - Delayed Quote USD

Assembly Biosciences, Inc. (ASMB)

13.36 -0.09 (-0.67%)
At close: April 25 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
7,163.00
7,163.00
--
6,254.00
79,105.00
Operating Expense
71,809.00
71,809.00
94,114.00
97,304.00
143,881.00
Operating Income
-64,646.00
-64,646.00
-94,114.00
-91,050.00
-64,776.00
Net Non Operating Interest Income Expense
3,451.00
3,451.00
1,022.00
302.00
2,624.00
Other Income Expense
5.00
--
--
-41,638.00
--
Pretax Income
-61,195.00
-61,195.00
-93,092.00
-132,386.00
-62,152.00
Tax Provision
33.00
33.00
--
-2,531.00
--
Net Income Common Stockholders
-61,228.00
-61,228.00
-93,092.00
-129,855.00
-62,152.00
Diluted NI Available to Com Stockholders
-61,228.00
-61,228.00
-93,092.00
-129,855.00
-62,152.00
Basic EPS
-160.56
--
-276.96
-36.00
-21.00
Diluted EPS
-160.56
--
-276.96
-36.00
-21.00
Basic Average Shares
381.45
--
336.18
3,606.70
2,952.26
Diluted Average Shares
381.45
--
336.18
3,606.70
2,952.26
Total Operating Income as Reported
-64,646.00
-64,646.00
-94,114.00
-132,688.00
-64,776.00
Total Expenses
71,809.00
71,809.00
94,114.00
97,304.00
143,881.00
Net Income from Continuing & Discontinued Operation
-61,228.00
-61,228.00
-93,092.00
-129,855.00
-62,152.00
Normalized Income
-61,228.00
-61,228.00
-93,092.00
-89,008.12
-62,152.00
Interest Income
3,451.00
3,451.00
1,022.00
302.00
2,624.00
Net Interest Income
3,451.00
3,451.00
1,022.00
302.00
2,624.00
EBIT
-64,646.00
-64,646.00
-94,114.00
-91,050.00
-64,776.00
EBITDA
-64,196.00
-64,196.00
-93,616.00
-90,584.00
-64,085.00
Reconciled Depreciation
450.00
450.00
498.00
466.00
691.00
Net Income from Continuing Operation Net Minority Interest
-61,228.00
-61,228.00
-93,092.00
-129,855.00
-62,152.00
Total Unusual Items Excluding Goodwill
--
--
--
-41,638.00
--
Total Unusual Items
--
--
--
-41,638.00
--
Normalized EBITDA
-64,196.00
-64,196.00
-93,616.00
-48,946.00
-64,085.00
Tax Rate for Calcs
0.00
0.00
--
0.00
--
Tax Effect of Unusual Items
--
--
--
-791.12
--
12/31/2020 - 12/17/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

EIGRQ Eiger BioPharmaceuticals, Inc.
3.0400
-19.95%
 
CTMX CytomX Therapeutics, Inc.
1.6000
-1.84%
 
SPRO Spero Therapeutics, Inc.
1.4300
+0.70%
 
TIL Instil Bio, Inc.
10.40
-1.89%
 
NXTC NextCure, Inc.
1.2900
-10.42%
 
GLPG.AS Galapagos NV
26.58
+0.08%
 
ALGS Aligos Therapeutics, Inc.
0.8180
-1.33%
 
GLPG Galapagos NV
28.63
-0.49%
 
PRTC.L PureTech Health plc
210.50
-0.94%
 
SYBX Synlogic, Inc.
1.8600
-1.06%